Intravesical Photodynamic Therapy ("PDT") in BCG-Unresponsive/Intolerant Non-Muscle Invasive Bladder Cancer ("NMIBC") Patients

Abroad (travel likely)RecruitingPHASE2

Conditions

Non-Muscle Invasive Bladder Cancer ("NMIBC") Unresponsive/Intolerant to BCG

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Site 02-012 - University of Chicago, Chicago, Illinois, United States
Contact: Study coordinator (Megan Mendez) · Megan.Mendez@medicine.bsd.uchicago.edu · 773-702-2081
Contact: Principal Investigator (Piyush Agarwal, MD)
Site 02-016 - Urology of Indiana, Greenwood, Indiana, United States
Contact: Study coordinator (Brittiny Currin) · bcurrin@urologyin.com · 631-838-6670
Contact: Principal Investigator (Dr. Eugene Cone)
Site 02-015 - Associated Medical Professionals of New York, Syracuse, New York, United States
Contact: Study coordinator (Nora Hoodmaker) · NHoodmaker@ampofny.com · 315-558-6619
Contact: Principal Investigator (Dr. Ilija Aleksic)
Site 02-017 - Central Ohio Urology Group, Gahanna, Ohio, United States
Contact: Study coordinator (Benjamin Carey) · bcarey@centralohiourology.com · 614-393-2684
Contact: Principal Investigator (Dr. Benjamin Martin)
Site 02-008 - MidLantic Urology, Bala-Cynwyd, Pennsylvania, United States
Site 02-006 - Carolina Urologic Research Center, Myrtle Beach, South Carolina, United States
Contact: Study coordinator (Jennifer Sutton) · jsutton@curcmb.com · 843-449-1010
Contact: Study coordinator (Jessica Richardson) · jrichardson@curcmb.com · 843-449-1010
Contact: Principal Investigator (Dr. Neal Shore, MD)
Site 02-007 - Urology Associates, P. C, Nashville, Tennessee, United States
Contact: Study coordinator (Tiffany Paine) · tmpaine@ua-pc.com · 615-250-9282
Contact: Principal Investigator (Dr. Gautam Jayram)
Site 02-010 - Urology San Antonio P. A, San Antonio, Texas, United States
Site 02-009 - Virginia Urology, Richmond, Virginia, United States
Site 02-011 - University of Wisconsin Health University Hospital, Madison, Wisconsin, United States
Contact: Study coordinator (Abigail Wiedmer) · wiedmer@urology.wisc.edu · 608-265-9172
Contact: Principal Investigator (Dr. Kyle Richards, MD)
Site 01-005 - The Vancouver Prostate Centre - Diamond Health Care Centre - Vancouver General Hospital, Vancouver, British Columbia, Canada
Contact: Study coordinator (Genevive Moreau) · gbaloloy@prostatecentre.com · 604-875-4111
Contact: Principal Investigator (Peter Black, MD)
Site 01-004 - Nova Scotia Health Authority - Centre for Applied Urology Research, Halifax, Nova Scotia, Canada
Contact: Study coordinator (Natasha Duggan) · natasha.duggan@nshealth.ca · 902-473-7969
Contact: Principal Investigator (Ricardo Rendon, M.D.)
Site 01-014 - St. Joseph's Healthcare, Hamilton, Ontario, Canada
Contact: Study coordinator (M. Teresa Balart, MD) · mbalart@stjoes.ca · (905) 522-1155
Contact: Study coordinator (Avinash Chekuri) · savinash@stjosham.on.ca
Contact: Principal Investigator (Dr. Bobby Shayegan)
Site 01-002- London Health Sciences Centre - Victoria Hospital, London, Ontario, Canada
Contact: Study coordinator (Wendy Shoff) · wendy.shoff@lhsc.on.ca · 519-685-8500
Contact: Principal Investigator (Jonathan Izawa, MD)
Site 01-001 - University Health Network - Princess Margaret Cancer Centre, Toronto, Ontario, Canada
Contact: Study coordinator (Sarah Cheung) · sarah.cheung@uhn.ca · 437-335-2949
Contact: Principal Investigator (Girish Kulkarni, MD)
Site 01-003 - McGill University Health Centre - Glen-Cedars Cancer Centre, Montreal, Quebec, Canada
Contact: Study coordinator (Karla Jauregui Sanchez) · karla.jaureguisanchez@muhc.mcgill.ca · 514-934-1934
Contact: Principal Investigator (Wassim Kassouf, MD)

Study leads

Girish Kulkarni, MD, FRCSC
Principal Investigator
University Health Network, Toronto

View source on ClinicalTrials.gov